Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for aggressive lung cancer: trial tests experimental drug combo

NCT ID NCT07155174

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug, ABBV-706, combined with an existing immunotherapy (atezolizumab) for people with a fast-spreading type of lung cancer who haven't had treatment yet. Researchers want to find the best dose, see if it's safe, and check if it works better than the current standard treatment at slowing the cancer's growth. About 180 adults worldwide will take part, receiving either the new combination or the standard treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Assuta Ashdod Medical Center /ID# 276661

    RECRUITING

    Ashdod, Southern District, 7747600, Israel

  • Chung Shan Medical University Hospital /ID# 277660

    RECRUITING

    Taichung, 402, Taiwan

  • Fort Wayne Medical Oncology And Hematology /ID# 277336

    RECRUITING

    Fort Wayne, Indiana, 46804, United States

  • Hadassah Medical Center-Hebrew University /ID# 276662

    RECRUITING

    Jerusalem, 91120, Israel

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 277267

    RECRUITING

    Kaohsiung City, 807, Taiwan

  • Meir Medical Center /ID# 277292

    RECRUITING

    Kfar Saba, Central District, 4428164, Israel

  • National Cancer Center Hospital /ID# 277237

    RECRUITING

    Chuo-Ku, Tokyo, 104-0045, Japan

  • Ocala Oncology Center /ID# 278269

    RECRUITING

    Ocala, Florida, 34474, United States

  • Rambam Health Care Campus- Haifa /ID# 276663

    RECRUITING

    Haifa, 3525408, Israel

  • Shizuoka Cancer Center /ID# 277243

    RECRUITING

    Sunto-gun, Shizuoka, 411-8777, Japan

  • Taipei Veterans General Hospital /ID# 277263

    RECRUITING

    Taipei, 112, Taiwan

  • The Chaim Sheba Medical Center /ID# 276660

    RECRUITING

    Ramat Gan, Tel Aviv, 5265601, Israel

  • The University of Texas MD Anderson Cancer Center /ID# 277929

    RECRUITING

    Houston, Texas, 77030, United States

  • Tokyo Metropolitan Komagome Hospital /ID# 277335

    RECRUITING

    Bunkyo Ku, Tokyo, 113-8677, Japan

  • University Hospitals Cleveland Medical Center /ID# 277556

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • Virginia Cancer Specialists - Fairfax /ID# 278298

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Wakayama Medical University Hospital /ID# 277260

    RECRUITING

    Wakayama, Wakayama, 641-8510, Japan

  • Yale University School of Medicine /ID# 278181

    RECRUITING

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.

SMALL CELL LUNG CANCER